XRCC1 and leukemia: The findings of the meta-analysis demonstrate that XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms are not associated with overall leukemia risk, but they could be associated with the risk for some specific leukemia entities [49].